123 related articles for article (PubMed ID: 38195445)
1. Esophageal cancer: a twenty-four-year experience at a tertiary care center with an evaluation of the prognostic significance of the neutrophil-lymphocyte ratio.
Mahmoud W; Hassoun L; Kerbage A; Mukherji D; Shamseddine A; Tamraz S; Hakim A; Barada K
BMC Gastroenterol; 2024 Jan; 24(1):27. PubMed ID: 38195445
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
3. Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China.
Yutong H; Xiaoli X; Shumei L; Shan S; Di L; Baoen S
Arch Med Res; 2015 Oct; 46(7):557-63. PubMed ID: 26385485
[TBL] [Abstract][Full Text] [Related]
4. Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patients.
Xu GW; Wu HR; Xiong R; Li CW; Liu CQ; Xu MQ; Xie MR
Thorac Cancer; 2018 Dec; 9(12):1707-1715. PubMed ID: 30311998
[TBL] [Abstract][Full Text] [Related]
5. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
Fu X; Li T; Dai Y; Li J
BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after radical resection of esophageal squamous cell carcinoma].
Chen H; He J
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):294-7. PubMed ID: 24989917
[TBL] [Abstract][Full Text] [Related]
7. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
8. A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: Neutrophil lymphocyte ratio/prealbumin ratio.
Lv Y; Zhang J; Liu Z; Tian Y; Liu F
Medicine (Baltimore); 2019 Feb; 98(7):e14562. PubMed ID: 30762804
[TBL] [Abstract][Full Text] [Related]
9. [Study on the prognostic influencing factors of esophageal squamous cell carcinoma and the predictive value of inflammatory reaction indexes on its postoperative recurrence].
Wang X; Wang Z; Lu WL; Zhao GF
Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):160-164. PubMed ID: 36781237
[No Abstract] [Full Text] [Related]
10. Baseline neutrophil-lymphocyte ratio holds no prognostic value for esophageal and junctional adenocarcinoma in patients treated with neoadjuvant chemotherapy.
van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; Barbour AP
Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31676907
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy.
Wang L; Zhu Y; Zhang B; Wang X; Mo H; Jiao Y; Xu J; Huang J
Thorac Cancer; 2022 Jun; 13(11):1631-1641. PubMed ID: 35437954
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for patients with locally advanced esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Li YQ; Zhu WG; Yu CH; Song YQ; Wang WW; He DC; Tao GZ; Tong YS
Sci Rep; 2017 Feb; 7():42581. PubMed ID: 28195186
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma.
Jung J; Park SY; Park SJ; Park J
Tumour Biol; 2016 Jun; 37(6):7149-54. PubMed ID: 26662960
[TBL] [Abstract][Full Text] [Related]
14. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.
Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Kurashige J; Hiyoshi Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Baba H
Surg Today; 2016 Apr; 46(4):405-13. PubMed ID: 26036223
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer.
Gao GD; Sun B; Wang XB; Wang SM
Int J Biol Markers; 2017 Oct; 32(4):e409-e414. PubMed ID: 28799624
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus.
Peleg N; Schmilovitz-Weiss H; Shamah S; Schwartz A; Dotan I; Sapoznikov B
Endoscopy; 2021 Aug; 53(8):774-781. PubMed ID: 33075822
[TBL] [Abstract][Full Text] [Related]
20. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma.
Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W
PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
